Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/05/2012CA2823306A1 Combination of components for the prevention and treatment of frailty
07/05/2012CA2823291A1 Antipyretic/analgesic composition
07/05/2012CA2823252A1 Plant essential oil-based antimicrobial fish filming compositions and methods of use
07/05/2012CA2823182A1 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
07/05/2012CA2823166A1 Orally disintegrating tablet
07/05/2012CA2823148A1 Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
07/05/2012CA2823138A1 Sirna for inhibition of hif1a expression and anticancer composition containing the same
07/05/2012CA2822995A1 Cellular hydration compositions containing cyclodextrins
07/05/2012CA2822921A1 Method for treating pancreatitis
07/05/2012CA2822853A1 Topical localized isoxazoline formulation comprising glycofurol
07/05/2012CA2822839A1 Topical localized isoxazoline formulation
07/05/2012CA2822754A1 Oral pharmaceutical tablet for controlled release of mesalazine and process for obtaining it
07/05/2012CA2822664A1 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
07/05/2012CA2822660A1 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
07/05/2012CA2822556A1 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012CA2822528A1 A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease
07/05/2012CA2822500A1 Human milk oligosaccharides to promote growth of beneficial bacteria
07/05/2012CA2822497A1 Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
07/05/2012CA2822495A1 Methods of using human milk oligosaccharides for improving airway respiratory health
07/05/2012CA2822490A1 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
07/05/2012CA2822222A1 Human milk oligosaccharides for modulating inflammation
07/05/2012CA2822219A1 Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
07/05/2012CA2822207A1 Oxidosqualene cyclase as a protein target for anticancer therapeutics
07/05/2012CA2822188A1 New biaryl amide derivatives
07/05/2012CA2822176A1 Small molecule conjugates for intracellular delivery of biologically active compounds
07/05/2012CA2822161A1 Small molecule conjugates for intracellular delivery of nucleic acids
07/05/2012CA2821863A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012CA2821340A1 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
07/05/2012CA2821312A1 Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
07/05/2012CA2820854A1 Heterocyclic compounds suitable for the treatment of dyslipidemia
07/05/2012CA2820087A1 Compositions and methods of using crystalline forms of wortmannin analogs
07/05/2012CA2818468A1 Treatment of pain associated with dislocation of basal endometrium
07/05/2012CA2817249A1 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof
07/04/2012EP2472262A2 Stromal interacting molecule knockout mouse and uses thereof
07/04/2012EP2471925A1 Methods and compositions related to riboswitches that control alternative splicing
07/04/2012EP2471920A2 Nucleic acid compounds for inhibiting WNT gene expression and uses thereof
07/04/2012EP2471918A1 Screening method
07/04/2012EP2471807A1 Long-acting polypeptides and methods of producing and administering same
07/04/2012EP2471804A1 Diadenosine antibacterial compounds
07/04/2012EP2471803A1 Compounds that interact with kinases
07/04/2012EP2471802A1 Phosphoramidates of monosaccharides
07/04/2012EP2471797A2 17-Desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents etc.
07/04/2012EP2471793A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471792A1 3-(biaryloxy) propionic acid derivative
07/04/2012EP2471791A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471790A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471789A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471787A1 New compounds
07/04/2012EP2471786A1 Aminopyrazole derivative
07/04/2012EP2471783A1 Novel polymorphic form of efavirenz
07/04/2012EP2471782A1 Novel sulfonamide derivative and pharmaceutical product containing same
07/04/2012EP2471781A1 Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same
07/04/2012EP2471780A1 Crystalline Ivabradine Oxalate Salts and Polymorphs Thereof
07/04/2012EP2471777A1 Novel tetrahydroisoquinoline compounds
07/04/2012EP2471774A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471773A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471770A1 Method of preparing polymorphic pure form A of bazedoxifene acetate
07/04/2012EP2471555A2 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
07/04/2012EP2471541A1 Medicine for dissolving and eliminating wart and excrescence consisting of protein and its uses
07/04/2012EP2471540A1 Compositions and methods for treating joints
07/04/2012EP2471539A1 Transdermal composition of phosphatidylcholine and method for producing same
07/04/2012EP2471538A1 The use of lpa for encouraging pregnancy, and fertility agent
07/04/2012EP2471537A1 Treatment of pain associated with dislocation of basal endometrium
07/04/2012EP2471536A1 Steroid analogs and characterization and treatment methods
07/04/2012EP2471535A1 Pharmaceutical composition for preventing or treating rheumatoid arthritis, containing rebamipide
07/04/2012EP2471534A1 Method of providing pirfenidone therapy to a patient
07/04/2012EP2471533A1 Aryl carbonyl derivatives as therapeutic agents
07/04/2012EP2471532A2 Agent containing indocyanine green and/or infracyanine green
07/04/2012EP2471531A2 Nitro-styrene derivatives having antimicrobial activity
07/04/2012EP2471530A1 Redox-active Therapeutics For Treatment Of Mitochondrial Diseases And Other Conditions And Modulation Of Energy Biomarkers
07/04/2012EP2471529A2 Kinase Inhibitors for Preventing or Treating Pathogen Infection and Method of Use Thereof
07/04/2012EP2471528A1 A preparation method for suspension of cetyl myristate and/or cetyl palmitate
07/04/2012EP2471527A2 Facially amphiphillc polymers and oligomers and uses thereof
07/04/2012EP2471526A2 Facially amphiphillic polymers and oligomers and uses thereof
07/04/2012EP2471525A2 Facially amphiphllic polymers and oligomers and uses thereof
07/04/2012EP2471524A2 Facially amphiphllic polymers and oligomers and uses thereof
07/04/2012EP2471522A1 Oral dosage form providing fast absorption of drug
07/04/2012EP2471521A1 Double-layer osmotic pump controlled release tablet of bicyclol and preparation method thereof
07/04/2012EP2471519A1 Controlled release formulation of carvedilol
07/04/2012EP2471518A2 Composition comprising oil drops
07/04/2012EP2471517A2 Rhein or diacerein compositions
07/04/2012EP2471516A2 Rhein or diacerein compositions
07/04/2012EP2471515A2 Rhein or diacerein compositions
07/04/2012EP2471514A1 Controlled moisture content of cetyl myristate and/or cetyl palmitate granules or formulations
07/04/2012EP2471513A1 Process for producing an active pharmaceutical ingredient (API) preparation in the form of beads
07/04/2012EP2471509A1 Methods and Ophthalmic Devices used in the Treatment of Ocular Allergies
07/04/2012EP2471508A1 Methods and Ophthalmic Devices used in the Treatment of Ocular Allergies
07/04/2012EP2471507A1 Methods and Ophthalmic Devices used in the Treatment of Ocular Allergies
07/04/2012EP2471388A1 Paediatric fibre mixture
07/04/2012EP2471387A1 Cetyl myristate and/or cetyl palmitate suspension formulations
07/04/2012EP2471386A1 Cetyl myristate and/or cetyl palmitate suspension formulations
07/04/2012EP2471385A1 Cetyl myristate and/or cetyl palmitate suspension formulations
07/04/2012EP2471384A1 Suspension formulations of cetyl myristate and/or cetyl palmitate
07/04/2012EP2471360A1 Improved tissue maintenance
07/04/2012EP2470657A2 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
07/04/2012EP2470655A1 Development of universal cancer drugs and vaccines
07/04/2012EP2470650A1 Breast cancer related gene c12orf32
07/04/2012EP2470553A1 Polyhydroxylated bile acids for treatment of biliary disorders
07/04/2012EP2470550A1 Bisphosphonates as inhibitors of acid sphingomyelinase
07/04/2012EP2470547A1 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents
1 ... 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 ... 7860